IP Library Patent Application 15596447
Patent Application
App. No. 15/596,447

COLLAGEN 7 AND RELATED METHODS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/596,447
Abstract

Disclosed are methods of making collagen 7, or functional fragments thereof, as well as collagen 7, and functional fragments thereof produced by such methods, nucleic acids encoding collagen 7, and functional fragments thereof, as well as vectors and host cells comprising such nucleic acids.

Claims (16)

1 - 42 . (canceled)

43 . A recombinant human collagen 7, or a functional fragment of human collagen 7, made by a method comprising:

providing a cell, which comprises an exogenously introduced nucleic acid that encodes human collagen 7, or a functional fragment thereof, wherein said cell is genetically manipulated to express one or more polypeptides that increase expression of human collagen 7, or a functional fragment thereof, and wherein the one or more polypeptides comprise prolidase;

culturing said cell under conditions sufficient for the production of human collagen 7, or the functional fragment thereof, and prolidase, thereby making human collagen 7, or the functional fragment thereof; and

recovering human collagen 7, or the functional fragment thereof, from said cell culture.

44 . The recombinant human collagen 7, or the functional fragment of human collagen 7, of claim 43 , wherein said cell is further genetically manipulated to express a glycosyl transferase.

45 . The recombinant human collagen 7, or the functional fragment of human collagen 7, of claim 43 , wherein said cell comprises an exogenously introduced nucleic acid that encodes prolidase.

46 . The recombinant human collagen 7, or the functional fragment of human collagen 7, of claim 44 , wherein said cell comprises an exogenously introduced nucleic acid that encodes glycosyl transferase.

47 . The recombinant human collagen 7, or the functional fragment of human collagen 7, of claim 43 , wherein said cell comprises an expression vector that comprises said exogenously introduced nucleic acid sequence that encodes human collagen 7, or the functional fragment thereof.

48 . The recombinant human collagen 7, or the functional fragment of human collagen 7, of claim 47 , wherein said expression vector further comprises a nucleic acid sequence that encodes prolidase.

49 . The recombinant human collagen 7, or the functional fragment of human collagen 7, of claim 48 , wherein said expression vector further comprises a nucleic acid sequence that encodes glycosyl transferase.

50 . The recombinant human collagen 7, or the functional fragment of human collagen 7, of claim 43 , wherein at least 30, 40, 50, 60, 70, 80, 90 or 95% of said human collagen 7, or the functional fragment thereof, is incorporated into homotrimers.

51 . The recombinant human collagen 7, or the functional fragment of human collagen 7, of claim 43 , wherein at least 30, 40, 50, 60, 70, 80, 90 or 95% of said human collagen 7, or the functional fragment thereof, is incorporated into hexamers.

52 . The recombinant human collagen 7, or the functional fragment of human collagen 7, of claim 43 , wherein the exogenously introduced nucleic acid that encodes human collagen 7, or the functional fragment thereof, is a highly glycine codon-optimized nucleic acid sequence.

53 . The recombinant human collagen 7, or the functional fragment of human collagen 7, of claim 43 , wherein said cell is a mammalian cell.

54 . The recombinant human collagen 7, or the functional fragment of human collagen 7, of claim 43 , wherein the method further comprises purifying human collagen 7, or the functional fragment thereof, from said cell culture.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 30, 2017
From: SHIRE HUMAN GENETIC THERAPIES, INC.; LOTUS TISSUE REPAIR, INC.
To: PHOENIX TISSUE REPAIR, INC.
Reel/Frame 043447/0805 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2017
From: VISWANATHAN, MALINI; DE SOUZA, MARK
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 042500/0256 →